MicroVascular Tissues Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $4.11M

  • Investors
  • 1

MicroVascular Tissues General Information

Description

Developer of vascular products designed to address vascular deficiencies. The company specializes in stem cell research and human allograft tissue deployment services, providing researchers and physicians with products useful in biological vascular tissue implantation.

Contact Information

Website
www.mvtissues.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6199 Cornerstone Court East
  • Suite 109
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 6199 Cornerstone Court East
  • Suite 109
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MicroVascular Tissues Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 10-Mar-2023 $4.11M Completed Generating Revenue
2. Early Stage VC (Series B) 12-Sep-2018 Completed Generating Revenue
1. Early Stage VC (Series A) 28-Aug-2014 $2.01M $2.01M Completed Startup
To view MicroVascular Tissues’s complete valuation and funding history, request access »

MicroVascular Tissues Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C
Series B
Series A 3,445,076 $0.001000 $1.15 $1.15 1x $1.15 24.96%
To view MicroVascular Tissues’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

MicroVascular Tissues Patents

  • 55

    Total Documents Applications and Grants

  • Total Patents Families

  • 42

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

MicroVascular Tissues Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200353008-A1 Compositions and methods for treating nerve injury Inactive 08-Jan-2018
CA-3086408-A1 Compositions and methods for treating nerve injury Inactive 08-Jan-2018
EP-3737355-A1 Compositions and methods for treating nerve injury Inactive 08-Jan-2018
AU-2019205822-A1 Compositions and methods for treating nerve injury Inactive 08-Jan-2018
EP-3737355-A4 Compositions and methods for treating nerve injury Inactive 08-Jan-2018 A61K9/0014
To view MicroVascular Tissues’s complete patent history, request access »

MicroVascular Tissues Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Pond Capital Venture Capital Minority
To view MicroVascular Tissues’s complete investors history, request access »

Ready to get started?

Request a free trial

MicroVascular Tissues FAQs

  • When was MicroVascular Tissues founded?

    MicroVascular Tissues was founded in 2014.

  • Where is MicroVascular Tissues headquartered?

    MicroVascular Tissues is headquartered in San Diego, CA.

  • What industry is MicroVascular Tissues in?

    MicroVascular Tissues’s primary industry is Discovery Tools (Healthcare).

  • Is MicroVascular Tissues a private or public company?

    MicroVascular Tissues is a Private company.

  • What is the current valuation of MicroVascular Tissues?

    The current valuation of MicroVascular Tissues is .

  • What is MicroVascular Tissues’s current revenue?

    The current revenue for MicroVascular Tissues is .

  • How much funding has MicroVascular Tissues raised over time?

    MicroVascular Tissues has raised $11.9M.

  • Who are MicroVascular Tissues’s investors?

    Pond Capital has invested in MicroVascular Tissues.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »